• Cancel
    Date：2021-01
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=829

    4Paradigm announced the closing of its Series D financing, raising $700 million. The round was led by Boyu Capital, Primavera Capital, and HOPU Investment, and included strategic investors such as the National Manufacturing Transformation Fund, China Deve

  • Cancel
    Date：2021-01

    CEC Capital Served as Financial Advisor

  • Cancel
    Date：2021-01
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=830

    HiveBox Holdings Limited plans to sign a "Share Purchase Agreement" and "Shareholders' Agreement" with Trustbridge Partners VII, L.P., AsiaForge (Cayman) Ltd., SCC Growth VI 2020 F, L.P., Redview Capital Investment VII Limited, All-Stars PEI ISP VI Limite

  • Cancel
    Date：2020-12
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=535

    CEC Capital Group serves as exclusive financial advisor Beijing Haosi (Health) Biotechnology Co., Ltd. (hereinafter referred to as "Haosi Bio" or the "Company"), a leading provider of solutions for clinical mass spectrometry detection, today announced th

  • Cancel
    Date：2020-12

    CEC Capital Served as Financial Advisor

  • Cancel
    Date：2020-12
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=508

    GaiaWorks (the “Company”), a workforce management cloud service provider, announced that it has completed its RMB 500 million Series D1 financing round, led by GGV Capital. Tencent Holdings, EDBI, and Index Capital China also participated in the round. Previous shareholders Matrix Partners China also increased their holdings in the Company.

  • Cancel
    Date：2020-11
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=525

    Tea brand CHALI (the “Company”) recently announced the closing of a Series B financing round of RMB 100 million. This round of financing was led by Country Garden Venture Capital, with CEC Capital Group’s investment fund and Wens (Guangdong) also participating in this round of investment. The proceeds from the financing will primarily be used for channel expansion and the construction of the Company’s Nansha R&D center. CHALI was established in August 2013. The Company is positioned as a packaged tea products and retail store brand. Its main products include herbal and fruit blended teas with over 600 million tea bags sold. During this year’s Double 11 Festival (November 11) in China, CHALI’s online sales ranked third in T-mall’s tea category and first in the herbal tea category. On JD.com, CHALI’s Peach Oolong Tea pouch sold 140,000 units, ranking No. 1 in single product sales in JD’s tea categories.

  • Cancel
    Date：2020-11
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=516

    Huiyihuiying (the “Company”) a leader in medical imaging artificial intelligence, announced that it has successfully completed its latest round (Series C2) of hundreds of millions of RMB in financing, one of the largest financings in the healthcare AI industry in China. This round of financing included new investors Shougang Fund, Sinopharm Junbai, and Kunjian Xintai, and existing shareholders including CDH Investments, Datai Capital, and Lanchi Ventures. CEC Capital Group served as the exclusive financial advisor of Huiyihuiying in this transaction.

  • Cancel
    Date：2020-11
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=530

    Beijing Megarobo Technologies Co., Ltd. (“Megarobo” or the “Company”) has recently completed a USD 30 million Series B financing round. This round of financing was led by Sinovation Ventures. Followers in the round included Liando Investment and existing shareholders Joy Capital and Robert Bosch Venture Capital. CEC Capital Group acted as the exclusive financial advisor of Megarobo in this transaction. Proceeds from this round will primarily be used to expand Megarobo’s core business, R&D efforts, the Company’s laboratory facilities, and to continue to build up the Company’s core capabilities in the field of life science automation.